Clearmind Medicine Inc. carries a market capitalization of 5.07M, placing it among publicly traded companies globally.
| Market Cap | 5.07M |
| Enterprise Value | N/A |
Clearmind Medicine Inc.'s stock has declined approximately -92.38095% over the past 52 weeks. The 50-day moving average sits at 2.07, while the 200-day moving average is 8.90.
| Beta (5Y) | N/A |
| 52-Week Price Change | -92.38095% |
| 50-Day Moving Average | 2.07 |
| 200-Day Moving Average | 8.90 |
| Average Volume (20 Days) | N/A |
Clearmind Medicine Inc.'s most recent stock split took place on November 28, 2023 with a 30:1 split ratio.
| Last Split Date | 11/28/2023 |
| Split Ratio | 30:1 |